Clinical risk factors for proliferative vitreoretinopathy
- PMID: 2757544
- DOI: 10.1001/archopht.1989.01070020213027
Clinical risk factors for proliferative vitreoretinopathy
Abstract
We reviewed the records of all patients with rhegmatogenous retinal detachments examined and treated by a single surgeon (B.P.C.) at the University of Virginia, Charlottesville, between 1978 and 1984. Of the 607 eyes that satisfied the selection criteria, a preliminary chart review of outcomes found that 65 (10.7%) had proliferative vitreoretinopathy and 34 had macular puckers. From the remaining 508 eyes, 325 controls were randomly selected to match each case from within a time window. Thirty-six (55.4%) of the 65 patients with proliferative vitreoretinopathy had had unequivocal reattachment after a single procedure before the onset of proliferative vitreoretinopathy, and the only clearly identified technical difficulty that was significantly more common in the patients with proliferative vitreoretinopathy was the inability to identify a retinal break. Several other features of the rhegmatogenous retinal detachments that correlated with the development of postoperative proliferative vitreoretinopathy were identified, and stepwise discriminant analysis was used to ascertain which of these were more important. The strongest predictor was use of vitrectomy in management of the detachment. Following this in order of importance were the presence of preoperative proliferative vitreoretinopathy, preoperative choroidal detachment, and the amount of cryopexy required. Vitrectomy remained a strong predictor even when considered after adjustment for all other characteristics. These data suggest that proliferative vitreoretinopathy is not simply an iatrogenic disease, but it is more likely to occur in association with certain detachment features that either by themselves or through their management require prolongation of the retinal wound healing process.
Similar articles
-
Clinical characteristics and surgical management of familial exudative vitreoretinopathy-associated rhegmatogenous retinal detachment.Retina. 2012 Feb;32(2):220-5. doi: 10.1097/IAE.0b013e31821c3ec5. Retina. 2012. PMID: 22277905
-
Perfluoropropane gas in the management of proliferative vitreoretinopathy.Am J Ophthalmol. 1984 Aug 15;98(2):180-8. doi: 10.1016/0002-9394(87)90353-9. Am J Ophthalmol. 1984. PMID: 6476045
-
Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study.Am J Ophthalmol. 2003 Sep;136(3):454-63. doi: 10.1016/s0002-9394(03)00241-1. Am J Ophthalmol. 2003. PMID: 12967798 Clinical Trial.
-
Proliferative vitreoretinopathy and chemotherapeutic agents.Surv Ophthalmol. 1985 May-Jun;29(6):434-42. doi: 10.1016/0039-6257(85)90208-5. Surv Ophthalmol. 1985. PMID: 3892742 Review.
-
Use of temporary keratoprosthesis in the management of severe ocular trauma with retinal detachment and proliferative vitreoretinopathy.Dev Ophthalmol. 1989;18:86-9. doi: 10.1159/000417093. Dev Ophthalmol. 1989. PMID: 2673881 Review. No abstract available.
Cited by
-
A case-control study to assess aspirin as a risk factor of bleeding in rhegmatogenous retinal detachment surgery.Graefes Arch Clin Exp Ophthalmol. 2015 Nov;253(11):1899-905. doi: 10.1007/s00417-014-2900-3. Epub 2015 Jan 11. Graefes Arch Clin Exp Ophthalmol. 2015. PMID: 25576171
-
An intravitreal biodegradable sustained release naproxen and 5-fluorouracil system for the treatment of experimental post-traumatic proliferative vitreoretinopathy.Br J Ophthalmol. 2004 Sep;88(9):1201-5. doi: 10.1136/bjo.2003.039917. Br J Ophthalmol. 2004. PMID: 15317716 Free PMC article.
-
Proliferative Vitreoretinopathy: A Review.Int Ophthalmol Clin. 2019 Winter;59(1):221-240. doi: 10.1097/IIO.0000000000000258. Int Ophthalmol Clin. 2019. PMID: 30585928 Free PMC article. Review.
-
Tamponade in surgery for retinal detachment associated with proliferative vitreoretinopathy.Cochrane Database Syst Rev. 2020 May 13;5(5):CD006126. doi: 10.1002/14651858.CD006126.pub4. Cochrane Database Syst Rev. 2020. PMID: 32408387 Free PMC article.
-
Vitreous levels of intercellular adhesion molecule 1 (ICAM-1) as a risk indicator of proliferative vitreoretinopathy.Br J Ophthalmol. 1999 Aug;83(8):953-6. doi: 10.1136/bjo.83.8.953. Br J Ophthalmol. 1999. PMID: 10413701 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical